Mira Pharmaceuticals Inc
MIRA1.570USD
+0.030+1.95%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.570USD+1.570After-hours (ET)
26.40MMarket Cap
LossP/E TTM
Mira Pharmaceuticals Inc
1.570
+0.030+1.95%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
Total equity
Cash, cash equivalents and short-term investments
-65.81%1.21M
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
1211.35%4.60M
--5.87M
--24.82K
-99.94%1.35K
--350.98K
--2.12M
- Cash and cash equivalents
-65.81%1.21M
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
1211.35%4.60M
--5.87M
--24.82K
-99.94%1.35K
--350.98K
--2.12M
Receivables
----
----
--0.00
--0.00
--0.00
--11.86K
----
----
----
----
----
-Other receivables
----
----
--0.00
--0.00
--0.00
--11.86K
----
----
----
----
----
Prepaid expenses
-14.42%158.61K
-77.55%54.73K
-57.32%86.57K
155.44%108.62K
208.73%185.34K
--243.80K
--202.82K
--42.52K
--60.03K
----
----
Other current assets
----
----
----
----
----
----
--0.00
--353.37K
89.69%189.69K
--143.43K
--100.00K
Total current assets
-63.25%1.36M
-40.56%2.89M
-30.31%4.23M
597.00%2.93M
1379.29%3.71M
882.64%4.86M
--6.07M
--420.72K
-88.70%251.07K
--494.40K
--2.22M
Non-current assets
Net Fixed Assets
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-99.13%1.27K
-98.61%5.06K
--114.36K
--132.33K
-24.55%146.51K
--363.67K
--194.19K
Other non-current assets
----
----
----
----
----
----
--2.78M
--3.22M
----
----
----
Total non-current assets
-62.60%35.44K
-52.25%35.44K
-98.80%35.44K
-97.56%83.17K
-35.32%94.76K
-79.59%74.21K
--2.95M
--3.40M
-82.09%146.51K
--363.67K
--818.04K
Total assets
-63.23%1.40M
-40.74%2.92M
-52.69%4.27M
-21.16%3.02M
857.99%3.81M
474.83%4.93M
--9.02M
--3.83M
-86.93%397.58K
--858.07K
--3.04M
Liabilities
Current liabilities
-Other payables
----
----
-100.00%0.00
-63.46%14.47K
-98.41%14.47K
-90.44%14.47K
--14.47K
--39.61K
869.97%907.88K
--151.34K
--93.60K
Accrued expenses
--5.50K
----
----
----
----
----
----
----
----
----
----
Short-term debt and lease liabilities
----
----
----
----
----
-100.00%0.00
--0.00
--1.80M
-9.68%219.54K
--133.06K
--243.06K
-Short-term debt
----
----
----
----
----
-100.00%0.00
--0.00
--1.80M
-9.68%219.54K
--133.06K
--243.06K
Other current liabilities
----
----
-100.00%0.00
-63.46%14.47K
-98.41%14.47K
-90.44%14.47K
--14.47K
--39.61K
869.97%907.88K
--151.34K
--93.60K
Total current liabilities
-83.72%106.17K
29.61%723.35K
-20.21%692.83K
-69.09%796.61K
-69.23%652.01K
-59.26%558.10K
--868.37K
--2.58M
296.59%2.12M
--1.37M
--534.26K
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--34.53K
--51.47K
-49.93%68.21K
--84.27K
--136.23K
-Long-term lease liabilities
----
----
----
-100.00%0.00
----
-100.00%0.00
--34.53K
--51.47K
-49.93%68.21K
--84.27K
--136.23K
Total non-current liabilities
----
----
----
-100.00%0.00
----
-100.00%0.00
--34.53K
--51.47K
-49.93%68.21K
--84.27K
--136.23K
Total liabilities
-83.72%106.17K
29.61%723.35K
-23.27%692.83K
-69.69%796.61K
-70.19%652.01K
-61.62%558.10K
--902.90K
--2.63M
226.19%2.19M
--1.45M
--670.49K
Shareholders' equity
Common equity
23.15%32.22M
22.13%31.34M
28.37%30.31M
105.34%26.91M
195.45%26.16M
194.72%25.66M
--23.61M
--13.11M
42.24%8.85M
--8.71M
--6.22M
Retained earnings
-34.42%-30.92M
-36.89%-29.14M
-72.53%-26.74M
-107.34%-24.69M
-116.12%-23.00M
-128.80%-21.29M
---15.50M
---11.91M
-186.16%-10.64M
---9.30M
---3.72M
Capital reserves
23.15%32.21M
22.13%31.34M
28.37%30.31M
105.44%26.91M
195.65%26.16M
194.92%25.66M
--23.61M
--13.10M
42.28%8.85M
--8.70M
--6.22M
Total equity
-59.00%1.29M
-49.71%2.20M
-55.96%3.57M
85.44%2.22M
276.41%3.16M
833.67%4.37M
--8.12M
--1.20M
-175.50%-1.79M
---596.23K
--2.37M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
